<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04628260</url>
  </required_header>
  <id_info>
    <org_study_id>213799</org_study_id>
    <nct_id>NCT04628260</nct_id>
  </id_info>
  <brief_title>UNCOVER - a Non-interventional Study to Investigate Undiagnosed Severe Asthma</brief_title>
  <official_title>UNCOVER - a Non-interventional Study to Investigate Undiagnosed Severe Asthma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karl Landsteiner Institute for Clinical and Experimental Pneumology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universitätsklinik für Innere Medizin II, Pulmologie</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karl Landsteiner Institute for Clinical and Experimental Pneumology</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      UNCOVER is a non-interventional study to investigate the prevalence of difficult-to-treat and&#xD;
      severe Asthma eligible for treatment with biologics in a cohort of patients with suspected,&#xD;
      so far undiagnosed severe Asthma which were previously treated by General practitioners and&#xD;
      Office-based pulmonologists.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 21, 2020</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The Primary objective is the Investigation of the prevalence of difficult-to-treat and severe Asthma eligible for Treatment with biologics.</measure>
    <time_frame>18 months</time_frame>
    <description>Number of patients with diagnosis of severe Asthma according to the ATS/ERS Definition of severe Asthma and number of severe Asthma patients eligible for one or more biologic Treatments for Asthma.</description>
  </primary_outcome>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Asthma</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Female and male patients are eligible for this non-interventional study when fulfilling all&#xD;
        criteria for inclusion and None of the criteria for exclusion. 400 patients will be&#xD;
        enrolled.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or older at inclusion&#xD;
&#xD;
          -  written informed consent&#xD;
&#xD;
          -  currently diagnosed with Asthma fulfilling at least one of the criteria of potential&#xD;
             severe Asthma&#xD;
&#xD;
          -  willing and able to complete the study questionnaire miniAQLQ&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  biological Treatment for Asthma during the past 12 months&#xD;
&#xD;
          -  participation in a clinical Trial within the last 3 months&#xD;
&#xD;
          -  patients who are not able to read or write, who do not understand the nature of the&#xD;
             study or the ICF or who are dependent from the investigator&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wolfgang Pohl, Univ. Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Head of Karl Landsteiner Institut for Clinical and Experimental Pneumology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karin Patocka, Mag.</last_name>
    <phone>+431801102471</phone>
    <email>karin.patocka@extern.gesundheitsverbund.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Karl Landsteiner Institute for Clinical and Experimental Pneumology, Klinik Hietzing</name>
      <address>
        <city>Vienna</city>
        <zip>1130</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karin Patocka, Mag.</last_name>
      <phone>+431801102471</phone>
      <email>karin.patocka@extern.gesundheitsverbund.at</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 6, 2020</study_first_submitted>
  <study_first_submitted_qc>November 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2020</study_first_posted>
  <last_update_submitted>November 11, 2020</last_update_submitted>
  <last_update_submitted_qc>November 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

